Risk factors
Enveric Biosciences (ENVB) risk factors
Item 1A of every Enveric Biosciences, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors69 risks2 new2 dropped9 reworded
Enveric Biosciences faces going concern and liquidity pressures while advancing its lead candidate EB-003 through preclinical stages.
Filed Mar 27, 2026 - 2025 10-K risk factors69 risks
Enveric Biosciences faces going concern doubts and critical funding needs for its lead drug candidate EB-003. Operations rely heavily on very few employees, early-stage research, and third-party partnerships. Regulatory hurdles, nascent psychedelic markets, and expiring licenses threaten commercialization timelines.
Filed Mar 28, 2025